Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

CNMD stock hub

CONMED Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CNMDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

CNMD

In the news

Latest news · CNMD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.1

P25 12.3P50 18.4P75 33.1

Trailing P/E20.8

P25 14.9P50 23.2P75 38.5

ROE5.5

P25 -105.6P50 -46.5P75 -3.1

ROIC4.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CNMD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

269

Groups with data

Currency

USD

Showing 269 of 269 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000816956
Company name	CONMED Corporation
Country	United States
Country code	US
Cusip	207410101
Employees	3,900
Employees Change	-100%
Employees Change Percent	-2.5
Enterprise value	$1.9B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	1987-07-23
Isin	US2074101013
Last refreshed	2026-05-10
Market cap	$1.1B
Market cap category	Small-Cap
Price	$36.76
Price currency	USD
Rev Per Employee	351,413.85x
Sector	Healthcare
Sic	3845
Symbol	CNMD
Website	https://www.conmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.96%
EV Earnings	35.24x
EV Sales Forward	1.38x
EV/EBIT	15.84x
EV/EBITDA	9.88x
EV/FCF	15.62x
EV/Sales	1.41x
FCF yield	11.18%
Forward P/E	8.13x
P/B ratio	1.09x
P/E ratio	20.77x
P/S ratio	0.81x
PE Ratio10 Y	397.13x
PE Ratio3 Y	28.07x
PE Ratio5 Y	37.68x
PEG ratio	1.6x
PS Forward	0.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.9%
EBITDA Margin	14.28%
FCF margin	9.03%
Gross margin	54.07%
Gross Profit	$741M
Gross Profit Growth	0.05%
Gross Profit Growth Q	0.22%
Gross Profit Growth3 Y	7.33%
Gross Profit Growth5 Y	8.91%
Net Income	$54.8M
Net Income Growth	-53.81%
Net Income Growth Q	129.09%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth5 Y	32.46%
Pretax Margin	5.97%
Profit Margin	4%
Profit Per Employee	$14,063
Profitable Years	3
ROA	3.31
Roa5y	3.52
ROCE	6.03
ROE	5.5
Roe5y	5.09
ROIC	4.39
Roic5y	5.71

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.51%
Cagr15y	3.02%
Cagr1y	-33.9%
Cagr20y	3.77%
Cagr3y	-32.97%
Cagr5y	-23.23%
Div CAGR10	0%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth	-53.56
EPS Growth Q	136.8
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth5 Y	31.97
FCF Growth	-24.82%
FCF Growth Q	-71.98%
FCF Growth3 Y	162.52%
FCF Growth5 Y	12.11%
OCF Growth	-20.49%
OCF Growth Q	-67.56%
OCF Growth10 Y	23.92%
OCF Growth3 Y	69.69%
OCF Growth5 Y	11.39%
Revenue Growth	4.14x
Revenue Growth Q	-1.31x
Revenue Growth Years	5x
Revenue Growth3 Y	7.65x
Revenue Growth5 Y	9.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.59
Assets	$2.3B
Cash	$35M
Current Assets	$670.6M
Current Liabilities	$292.7M
Debt	$860.9M
Debt EBITDA	$4.17
Debt Equity	$0.85
Debt FCF	$6.96
Equity	$1B
Interest Coverage	4.09
Liabilities	$1.3B
Long Term Assets	$1.6B
Long Term Liabilities	$1B
Net Cash	$-825.8M
Net Cash By Market Cap	$-74.61
Net Debt EBITDA	$4.22
Net Debt Equity	$0.81
Net Debt FCF	$6.68
Tangible Book Value	$-363M
Tangible Book Value Per Share	$-12.04
WACC	6.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.29
Inventory Turnover	1.75
Net Working Capital	$343.6M
Quick ratio	0.9
Working Capital	$377.9M
Working Capital Turnover	$3.74

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.33%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	$0.4
Dividend Years	14
Dividend Yield	1.09%
Ex Div Date	2025-09-15
Last Dividend	$0.2
Payout Ratio	22.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-5.01%
1Y total return	-33.88%
200-day SMA	43.86
3Y total return	-69.89%
50-day SMA	37.79
50-day SMA vs 200-day SMA	50under200
5Y total return	-73.34%
All Time High	159.1
All Time High Change	-76.9%
All Time High Date	2021-11-05
All Time Low	0.81
All Time Low Change	4,411.54%
All Time Low Date	1987-10-20
ATR	1.8
Beta	0.94
Beta1y	1.46
Beta2y	0.7
Ch YTD	-9.46
High	38.7
High52	61.08
High52 Date	2025-05-12
High52ch	-39.82%
Low	36.55
Low52	33.21
Low52 Date	2026-03-30
Low52ch	10.69%
Ma50ch	-2.71%
Price vs 200-day SMA	-16.19%
RSI	47.01
RSI Monthly	34.24
RSI Weekly	40.6
Sharpe ratio	-0.96x
Sortino ratio	-1.14
Total Return	1.42%
Tr YTD	-9.46
Tr15y	56.16%
Tr1m	6.43%
Tr1w	-0.11%
Tr3m	-11.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Ratings	Hold
Earnings EPS Estimate	$0.82
Earnings EPS Estimate Growth	-13.68
Earnings Revenue Estimate	310,611,280x
Earnings Revenue Estimate Growth	-3.33x
Operating Income	$122M
Operating Income Growth	-20.02
Operating Income Growth Q	-28.23
Operating Income Growth3 Y	11.41
Operating Income Growth5 Y	10.38
Operating margin	8.9
Price target	$42.4
Price Target Change	$15.34

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	29,826,684%
Float Percent	99.06%
Net Borrowing	-34,999,000
Shares Insiders	0.87%
Shares Institutions	113.28%
Shares Out	30,109,194
Shares Qo Q	-1.32%
Shares Yo Y	-0.33%
Short Float	2.84%
Short Ratio	5.6
Short Shares	2.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$103.7M
Average Volume	447,677.3x
Bv Per Share	33.76
CAPEX	$-18.9M
Ch10y	-14.35
Ch15y	29.94
Ch1m	6.43
Ch1w	-0.11
Ch1y	-34.37
Ch20y	74.38
Ch3m	-11.46
Ch3y	-70.68
Ch5y	-74.41
Ch6m	-16.4
Change	-3.52%
Change From Open	-3.29
Close	38.1
Days Gap	-0.24
Depreciation Amortization	73,665,000
Dollar Volume	14,232,222.2
Earnings Date	2026-04-29
Earnings Time	amc
EBIT	$122M
EBITDA	$195.7M
EPS	$1.77
F Score	7
FCF	$123.7M
FCF EV Yield	6.4x
FCF Per Share	$4.11
Financing CF	-129,975,000
Fiscal Year End	December
Founded	1,970
Goodwill	806,858,000
Graham Number	36.66654
Graham Upside	-0.25
Income Tax	$27M
Investing CF	-13,919,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2001-09-10
Last Split Type	Forward
Last10k Filing Date	2026-02-17
Lynch Fair Value	$44.25
Lynch Upside	20.37
Ma150	41.18
Ma150ch	-10.74%
Ma20	37.79
Ma20ch	-2.72%
Net CF	-455,000
Next Earnings Date	2026-07-29
Open	38.01
Optionable	Yes
P FCF Ratio	8.95
P OCF Ratio	7.76
Payment Date	2025-10-03
Position In Range	9.77
Ppne	111,964,000
Price Date	2026-05-08
Price EBITDA	$5.66
Relative Volume	0.86x
Revenue	1,370,514,000x
SBC By Revenue	1.46x
Share Based Comp	19,962,000
Tax By Revenue	1.97x
Tax Rate	32.95%
Tr20y	109.58%
Tr6m	-16.4%
Us State	Florida
Volume	387,166
Z Score	2.01

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

CNMD dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$0.40 annual per share

Payout ratio

+22.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

+1.4%

Next ex-dividend date: 2025-09-15

Performance

CNMD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CNMD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+113.3%

Float: +99.1% of shares outstanding

Insider ownership

+0.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CNMD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.0

Neutral momentum band

Price vs 200-day MA

-16.2%

50/200-day relationship not available

Beta (5Y)

0.94

Moves roughly with the market

Sharpe ratio

-0.96

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CNMD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CNMD stock rating?

CONMED Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CNMD analysis?

The full report lives at /stocks/CNMD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CNMD?

The latest report frames CNMD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CNMD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.